What’s ENTenna?

Asia’s First Precision Navigator for Allergic Rhinitis. ENTenna is a data-driven ecosystem designed to transform how we manage chronic allergies. By combining Asia’s largest allergy database with AI-powered tools, we provide personalized, proactive care for those living with allergic rhinitis.

LEARN MORE

request a demo

*Displayed data represents dummy profiles for demonstration purposes only.

Personalised for You.

Precision for All.

ENTenna moves away from "one-size-fits-all" treatments to focus on the specific environmental and genetic triggers found in the population.

The patient experience

  • AI symptom tracking uses simple tools to log symptoms and generate personalized flare-up predictions.
  • Digital companion provides automated medication reminders and real-time environmental alerts via WhatsApp.
  • Travel-ready advice offers tailored tips to manage allergies across different climates and locations.
  • Proactive prevention shifts the focus from reactive symptom relief to predictive, data-backed care.

*Displayed data represents a dummy profile for demonstration purposes only.

From data points to patient paths

  • Predictive symptom modeling to visualise symptom progression over 24 weeks using 8-week moving averages
  • Live monitoring of weekly and monthly response rates alongside “current streaks” to ensure data reliability.
  • Instant identification of high-risk patients via a “Risk Level” status indicator based on liver survey data

Visualising the Pulse of Population Health

  • Dynamic population profiling with demographic breakdown by age, gender, and ethnicity for targeted clinical insight.
  • Clinical enrollment oversight to ensure product capacity aligns with clinical resources and outreach goals.

From Data to Better Breathing

Best Practice Medal (Care Redesign)

ENTenna by the Numbers

An ICER of

$19,995

per QALY

25%

of patients with low symptom scores right sited to community care

Reduced review Visits by

0.63

per patient annually

Estimated Cost Avoidance of

S$1.4k

per patient

about us

PLatform

product suites

NEWS

REQUEST A DEMO

What’s ENTenna?

Asia’s First Precision Navigator for Allergic Rhinitis. ENTenna is a data-driven ecosystem designed to transform how we manage chronic allergies. By combining Asia’s largest allergy database with AI-powered tools, we provide personalized, proactive care for those living with allergic rhinitis.

LEARN MORE

request a demo

*Displayed data represents dummy profiles for demonstration purposes only.

Personalised for You.

Precision for All.

ENTenna moves away from "one-size-fits-all" treatments to focus on the specific environmental and genetic triggers found in the population.

The patient experience

  • AI symptom tracking uses simple tools to log symptoms and generate personalized flare-up predictions.
  • Digital companion provides automated medication reminders and real-time environmental alerts via WhatsApp.
  • Travel-ready advice offers tailored tips to manage allergies across different climates and locations.
  • Proactive prevention shifts the focus from reactive symptom relief to predictive, data-backed care.

From data points to patient paths

  • Predictive symptom modeling to visualise symptom progression over 24 weeks using 8-week moving averages
  • Live monitoring of weekly and monthly response rates alongside “current streaks” to ensure data reliability.
  • Instant identification of high-risk patients via a “Risk Level” status indicator based on liver survey data

*Displayed data represents a dummy profile for demonstration purposes only.

Visualising the Pulse of Population Health

  • Dynamic population profiling with demographic breakdown by age, gender, and ethnicity for targeted clinical insight.
  • Clinical enrollment oversight to ensure product capacity aligns with clinical resources and outreach goals.

From Data to Better Breathing

Best Practice Medal (Care Redesign)

ENTenna by the Numbers

An ICER of

$19,995

per QALY

25%

of patients with low symptom scores right sited to community care

Estimated Cost Avoidance of

S$1.4k

per patient

Reduced review Visits by

0.63

per patient annually